Home - Prescription Medicines - KaShuangPing® | Pioglitazone Hydrochloride and Metformin Hydrochloride Tablets | Type 2 Diabetes | DengYueRX
Description
Indication & Scope
KaShuangPing® Pioglitazone Hydrochloride and Metformin Hydrochloride Tablets indicates for type 2 diabetes mellitus, improves insulin resistance and controls blood glucose level.
- Mechanism: Metformin reduces hepatic glucose output and increases peripheral glucose uptake; pioglitazone activates peroxisome proliferator‑activated receptor gamma, improves insulin resistance, and together they synergistically lower blood sugar.
- Drug class: Oral hypoglycemic compound preparation for type 2 diabetes.
- Clinical use: Blood glucose control in patients with type 2 diabetes who have insulin resistance.
| Generic Name | Pioglitazone Hydrochloride and Metformin Hydrochloride Tablets |
| Brand Name | KaShuangPing® |
| Ingredient | Pioglitazone Hydrochloride, Metformin Hydrochloride |
| Dosage Form | Tablets |
| Package | [Pioglitazone hydrochloride (calculated as pioglitazone) 15mg + Metformin hydrochloride 500mg]*30 tablets/box;
[Pioglitazone hydrochloride (calculated as pioglitazone) 15mg + Metformin hydrochloride 500mg]*14 tablets/box; [Pioglitazone hydrochloride (calculated as pioglitazone) 15mg + Metformin hydrochloride 500mg]*18 tablets/box |
| Conditions Treated | Type 2 diabetes mellitus |
| Taboos | Contraindicated for hypersensitivity to pioglitazone, metformin or excipients. Contraindicated in diabetic ketoacidosis, severe heart failure, severe renal and hepatic insufficiency |
| Place of origin | China |
| Prescription type | Prescription‑only |
| Storage Conditions | Seal, store at room temperature below 25℃, avoid light and moisture |
| Manufacturer | Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. |
| Registration Authority | National Medical Products Administration (NMPA), China |
| Approval number | H20100180 |
| Approval Date | Mar 25, 2025 |
| Shelf Life | 24 months |
How to use ?
Recommended Dose: 1 tablet per single administration, adjusted according to blood glucose monitoring results.
Time: Orally taken once or twice daily with meals.
Instructions for use: Take with meals to reduce gastrointestinal irritation. Regular monitoring of fasting and postprandial blood glucose, liver function and weight is required. Early symptoms of lactic acidosis (muscle soreness, dyspnea) require immediate medical treatment.
Interaction: Concomitant use of sulfonylurea hypoglycemics increases hypoglycemia risk. Cimetidine may increase metformin plasma concentration.
Side effects: Mild nausea, diarrhea, weight gain; rare lactic acidosis, edema, liver function abnormality.
Important Notice
This product should be administered only by qualified healthcare professionals in accordance with the approved prescribing information and local clinical guidelines. Dosage and administration may vary depending on patient condition, indicatiaon, and regional regulatory requirements.
Packaging & Shipping
Packaging
Original manufacturer’s packaging with secure export carton. Customized export packaging is available upon request.
Shipping Methods
Express Courier (EMS, DHL, FedEx, UPS), Air Freight, and Sea Freight. Cold-chain transportation is available for products requiring temperature-controlled logistics.
Export Support
Certificate of Analysis
GMP Certificate
Commercial Invoice
Packing List & CPP
Cold Chain Logistics
Customs Documentation
Scientific and regulatory sources
FAQ
When is Pioglitazone Hydrochloride and Metformin Hydrochloride Tablets taken to reduce gastrointestinal irritation?
It should be taken together with meals to alleviate gastrointestinal adverse reactions.
What serious adverse reaction needs emergency medical treatment of Pioglitazone Hydrochloride and Metformin Hydrochloride Tablets?
Muscle soreness, dyspnea and fatigue may indicate lactic acidosis and require immediate hospital visit.
Which diabetic complication is contraindicated for Pioglitazone Hydrochloride and Metformin Hydrochloride Tablets?
Diabetic ketoacidosis is an absolute contraindication for pioglitazone metformin tablets.
What index needs regular monitoring during long‑term use of Pioglitazone Hydrochloride and Metformin Hydrochloride Tablets?
Blood glucose, liver function and body weight need regular detection.
KaShuangPing® | Pioglitazone Hydrochloride and Metformin Hydrochloride Tablets | Type 2 Diabetes | DengYueRX
INN: Pioglitazone Hydrochloride and Metformin Hydrochloride Tablets
Indications: Type 2 diabetes
Dosage Form: Tablets
Strength: [Pioglitazone hydrochloride (calculated as pioglitazone) 15mg + Metformin hydrochloride 500mg] /tablet
$18.66 Original price was: $18.66.$15.86Current price is: $15.86.